1. Academic Validation
  2. Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma

Potential role of the P2X7 receptor in the proliferation of human diffused large B-cell lymphoma

  • Purinergic Signal. 2023 May 24. doi: 10.1007/s11302-023-09947-w.
Xiao Yang 1 Yuanyuan Ji 2 Lin Mei 2 Wenwen Jing 2 Xin Yang 3 Qianwei Liu 4
Affiliations

Affiliations

  • 1 Scientific Research Center and Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, China. yang_x@xjtu.edu.cn.
  • 2 Scientific Research Center and Precision Medical Institute, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, China.
  • 3 Department of Rheumatology, The Second Affiliated Hospital, Xi'an Jiaotong University, Xi'an, 710004, China.
  • 4 Institute of Environmental Medicine, Karolinska Institutet, Stockholm, 17177, Sweden.
Abstract

Diffuse large B-cell lymphoma (DLBCL) is the most common subtype of invasive non-Hodgkin lymphoma. 60-70% of patients are curable with current chemoimmunotherapy, whereas the rest are refractory or relapsed. Understanding of the interaction between DLBCL cells and tumor microenvironment raises the hope of improving overall survival of DLBCL patients. P2X7, a member of purinergic receptors P2X family, is activated by extracellular ATP and subsequently promotes the progression of various malignancies. However, its role in DLBCL has not been elucidated. In this study, the expression level of P2RX7 in DLBCL patients and cell lines was analyzed. MTS assay and EdU incorporation assay were carried out to study the effect of activated/inhibited P2X7 signaling on the proliferation of DLBCL cells. Bulk RNAseq was performed to explore potential mechanism. The results demonstrated high level expression of P2RX7 in DLBCL patients, typically in patients with relapse DLBCL. 2'(3')-O-(4-benzoylbenzoyl) adenosine 5-triphosphate (Bz-ATP), an agonist of P2X7, significantly accelerated the proliferation of DLBCL cells, whereas delayed proliferation was detected when administrated with antagonist A740003. Furthermore, a urea cycle Enzyme named CPS1 (carbamoyl phosphate synthase 1), which up-regulated in P2X7-activated DLBCL cells while down-regulated in P2X7-inhibited group, was demonstrated to involve in such process. Our study reveals the role of P2X7 in the proliferation of DLBCL cells and implies that P2X7 may serve as a potential molecular target for the treatment of DLBCL.

Keywords

CPS1; Diffuse large B-cell lymphoma; P2X7; Proliferation; Purinergic receptor.

Figures
Products